Furosemide vs Indapamide: Key Differences
Furosemide is a potent loop diuretic acting on the loop of Henle with a short 6-8 hour duration, while indapamide is a thiazide-like diuretic acting on the distal tubule with a prolonged 36-hour duration and additional direct vasodilatory effects.
Mechanism of Action
Furosemide inhibits the Na⁺-K⁺-2Cl⁻ cotransporter (NKCC2) in the thick ascending limb of the loop of Henle, blocking sodium and chloride reabsorption at this site 1. This location gives it high efficacy for rapid fluid removal. The drug acts at the luminal surface and must be actively secreted into the tubular lumen via the organic acid pump to reach its site of action 1, 2.
Indapamide acts primarily on the distal convoluted tubule like other thiazide-like diuretics 3. However, it has a unique dual mechanism: beyond its diuretic effect, it exerts direct vascular actions, likely through calcium channel blockade, causing vasodilation 4, 5. This direct vascular effect distinguishes it from pure diuretics and contributes to its antihypertensive properties independent of volume depletion.
Dosing and Duration
Furosemide:
- Initial dose: 20-40 mg once or twice daily
- Maximum dose: 600 mg daily
- Duration of action: 6-8 hours
- Onset: Within 1 hour, peak effect at 1-2 hours 6, 1
Indapamide:
- Initial dose: 2.5 mg once daily
- Maximum dose: 5 mg daily
- Duration of action: 36 hours
- Allows once-daily dosing 6
The shorter duration of furosemide requires twice-daily dosing in many patients, while indapamide's prolonged action permits convenient once-daily administration 6.
Clinical Context and Efficacy
Furosemide is the most commonly used loop diuretic for acute congestion and fluid overload in heart failure 6. It provides powerful, rapid diuresis essential for managing acute decompensated heart failure. However, its effects on morbidity and mortality are uncertain, and it should always be combined with guideline-directed medical therapy 6.
Indapamide is primarily used for hypertension management and is one of the thiazide-like agents used in cardiovascular outcome trials demonstrating event reduction 3. When combined with furosemide in refractory heart failure, indapamide shows comparable efficacy to metolazone-furosemide combinations for sodium excretion and urine output 7.
Adverse Effect Profile
Furosemide:
- Hypokalemia (common, dose-dependent)
- Hyponatremia
- Hypovolemia and hypotension
- Hyperuricemia
- Ototoxicity (with high doses or rapid IV administration)
- Metabolic alkalosis
- Renal function decline (especially with aggressive diuresis activating tubuloglomerular feedback) 1, 2
Indapamide:
- Hypokalemia: 20% of patients on 1.25 mg had K⁺ <3.4 mEq/L, with only 2% having symptomatic hypokalemia 8
- Hyponatremia (less common than with furosemide)
- Hyperuricemia and hyperglycemia
- Headache, dizziness, fatigue
- Rare: photosensitivity, Stevens-Johnson syndrome
- Notable: Does not adversely affect lipid profiles 8
The most common adverse event with both agents is hypokalemia, occurring in 66% of patients in comparative studies 7. However, indapamide at lower doses (1.25 mg) shows better tolerability with about 40% of hypokalemic patients returning to normal potassium without intervention 8.
Important Clinical Considerations
Furosemide resistance is a major pitfall, occurring with:
- High dietary sodium intake
- NSAID co-administration
- Impaired renal perfusion or function
- Chronic use leading to compensatory sodium retention 6
Overcome resistance by escalating doses, switching to IV administration, or combining with thiazide-like diuretics such as indapamide 6.
Indapamide's vascular effects provide antihypertensive benefits beyond diuresis, making it particularly useful in hypertensive patients with mild fluid retention 4, 5. It remains effective even in renal impairment, though advantages over furosemide in this setting are questionable 4.
Bioavailability concerns: Furosemide has highly variable oral bioavailability (averaging 64%), which contributes to unpredictable responses 1, 9. Some patients respond better to other loop diuretics like torsemide or bumetanide due to superior oral bioavailability 6.